Multidrug Resistance Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Condition: Tuberculosis, Multidrug-Resistant Interventions: Drug: Bedaquiline; Drug: Levofloxacin; Drug: Linezolid; Drug: Cycloserine; Drug: Clofazimine; Drug: Pyrazinamide; Drug: Protionamide Sponsor: Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials
Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries
Conditions: Drug Resistance, Multiple, Bacterial; Cholangiopancreatography, Endoscopic Retrograde Interventions: Diagnostic Test: MDRO-testing through rectal and oral/nasal swabs; Diagnostic Test: MDRO-testing duodenal aspirate; Diagnostic Test: Microbiome through rectal swab; Diagnostic Test: Microbiome testing duodenal aspirate Sponsors: Marco J. Bruno; Boston Scientific Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials